Prostate Cancer Trial Results Announced Profound Medical announced promising results from their TULSA-PRO ablation clinical trial in patients with prostate cancer, which was designed to support Profound’s FDA application to market the device in the United States.
READ MORE >
|
|
|
Theraclion Obtains CE Mark for Treatment of Varicose Veins
In April, Theraclion announced that it had obtained the CE mark for its newly developed SONOVEIN® focused ultrasound system for the treatment of varicose veins.
READ MORE > |
|
Cardiawave Begins First Human Aortic Stenosis Clinical Trial
Cardiawave, a focused ultrasound company with a mission to reduce aortic valve stenosis caused by calcification, will soon begin clinical trials to test its Valvopulse device.
READ MORE > |
|
Foundation Honored at THRiVE 2019 Conference
Chairman Neal F. Kassell, MD, accepted an award on behalf of the Foundation for Outstanding Contributions to Virginia Bioscience at the THRiVE 2019 conference.
READ MORE > |
|
Foundation Welcomes New Council Members
The Foundation is pleased to announce Allan Stam and Deborah Caldwell have joined the Foundation’s Council, a dedicated group of goodwill ambassadors.
READ MORE > |
|
Board Update: Fred Moll Sells Auris to Johnson & Johnson, Appointed Chief Development Officer
Longtime Foundation Board Member, Frederic H. Moll, MD, sold his medical robotics company, Auris Health, Inc., to Johnson & Johnson (J&J) for $3.4 billion and was appointed Chief Development Officer at J&J.
READ MORE > |
|
May is Mental Health Month
The Foundation recognizes mental health conditions as serious medical diseases and supports researchers exploring focused ultrasound to treat them.
READ MORE > |
|
OCD Patient Treated in Toronto
Jeffrey is the first person in North America to participate in a clinical trial at Sunnybrook Health Sciences Centre investigating the use of focused ultrasound to treat OCD.
READ HIS STORY > |
|
Ohio State Joins Alzheimer’s Clinical Trial
The OSU Wexner Medical Center announced the start of a clinical trial using focused ultrasound to open the blood-brain barrier in patients with Alzheimer's disease.
READ MORE > |
|
Focused Ultrasound Study for Pets Funded by Petco Foundation, Blue Buffalo
A focused ultrasound study for pets, which will help inform how the technology can be used to treat tumors in humans, is being funded by Petco Foundation and Blue Buffalo.
READ MORE > |
|
Meeting Report: American Urological Association 2019 Meeting
The American Urological Association annual meeting was held May 3-6, where high-intensity focused ultrasound for prostate and kidney applications were featured.
READ MORE > |
|
Research Roundup
An international group of clinicians determined whether skull density ratio impacted safety or efficacy for essential tremor patients when treated with focused ultrasound.
READ MORE > |
|
| Visit our free, online research library of focused ultrasound publications. |
|
June 9-13, 2019 14th Biennial Congress and Exhibition of the International Stereotactic Radiosurgery Society (ISRS), Rio de Janeiro, Brazil
June 10-11, 2019 Society for Image Guided Neurointerventions (SIGN), Baltimore, Maryland
June 12-15, 2019 Ultrasound Energy - ISTU and EUFUS Joint Meeting, Barcelona, Spain
June 20-21, 2019 WSGR Medical Device Conference, San Francisco, California
June 24-27, 2019 World Society for Stereotactic and Functional Neurosurgery (WSSFN) 18th Biennial Meeting, New York, New York
July 14-18, 2019 Alzheimer’s Association International Conference (AAIC), Los Angeles, California
July 14-18, 2019 American Association of Physicists in Medicine Annual Meeting (AAPM), San Antonio, Texas
July 23-27, 2019 IEEE 41st International Engineering in Medicine and Biology Conference (EMBC), Berlin, Germany
August 2-6, 2019 American Veterinary Medicine Association Convention (AVMA), Washington, DC
August 16-17, 2019 Society for NeuroOncology (SNO) – Inaugural Conference on Brain Metastases, New York, New York
August 29-31, 2019 5th World Congress on Parkinsons & Huntington Disease, Vienna, Austria |
|
|
|
